M-TRAM is part of an exceptional eco-system comprising Stanford University’s world-class medical research, bioengineering, biomedical technology, and business experts, as well as leading biotechnology and pharmaceutical industry leaders. These collaborations offer students myriad opportunities to advance their knowledge, skills and careers.

• Stanford Cancer Institute (SCI) 

• Stanford Cardiovascular Institute (CVI) 

• Innovative Medicines Accelerator (IMA) 

• Sarafan ChEM-H 

• Maternal & Child Health Research Institute (MCHRI) 

• Institute for Stem Cell Biology & Regenerative Medicine 

• Canary Center for Early Cancer Detection Quantitative Sciences Unit (QSU) 

• Clinical & Translational Research Unite (CTRU)

The Translational Research and Applied Medicine (TRAM) Center has over 100 associated Stanford faculty, many of whom are international leaders in translational medicine who support M-TRAM and are strong mentors to our students.

Integral to the program is the experience students gain from biotech/pharma partners. The Translational Research and Applied Medicine (TRAM) Center already has ongoing industry partnerships with many biotech companies: 

• Revolution Medicines
• ProteinSimple
• EMulate
• RainDance Technologies
• Bio-Techne

Additionally, through the collaboration with the department of Pediatrics MCHRI Drug and Device Development Training Program (D3), M-TRAM will offer internships with an industry partner that will feature immersive experiences within the firm’s operations. The D3 program has successfully matched their interns at various Biotech/Pharma partners, including Pfizer, GlaxoSmithKline and Johnson & Johnson.